E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 7, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 306
- +14 vs. Q3 2023
- Portfolio value
- $1.58B
- +$264.0M (+20.1%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BZKanzhun Ltd | SPONSORED ADS | 2,422,718 | $40.2M | 2.5% | +55,077+2.3% | Added | History |
| AMDAdvanced Micro Devices Inc | Stock | 309,049 | $45.6M | 2.9% | +5,611+1.8% | Added | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 557,291 | $58.0M | 3.7% | −92,709−14.3% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 155,346 | $58.4M | 3.7% | −13,090−7.8% | Reduced | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 5,043,810 | $81.8M | 5.2% | −66,116−1.3% | Reduced | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 4,581,940 | $670.4M | 42.5% | −72,503−1.6% | Reduced | History |
Sold out since Q3 2023 (24)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| MNSOMINISO Group Holding Ltd | SPONSORED ADS | 83,775 | $2.17M | 0.2% | History |
| Invesco QQQ Tr46090E107 | UNIT SER 1 | 2,487 | $891.0K | 0.1% | – |
| SGENSeagen Inc. | COM | 4,008 | $850.0K | 0.1% | History |
| Direxion Shs ETF Tr25460G781 | DLY GOLD INDX 2X | 19,373 | $517.0K | <0.1% | – |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 3,962 | $458.0K | <0.1% | History |
| ENPHEnphase Energy, Inc. | Stock | 2,526 | $303.0K | <0.1% | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 15,728 | $292.0K | <0.1% | History |
| EBAYeBay Inc | COM | 5,852 | $258.0K | <0.1% | History |
| GLWCorning Inc | COM | 6,971 | $212.0K | <0.1% | History |
| MYGNMyriad Genetics Inc | COM | 10,709 | $172.0K | <0.1% | History |
| TAT&T Inc. | Stock | 11,172 | $168.0K | <0.1% | History |
| CHRSCoherus Oncology, Inc. | COM | 45,010 | $168.0K | <0.1% | History |
| BMEABiomea Fusion, Inc. | COM | 12,010 | $165.0K | <0.1% | History |
| ALLOAllogene Therapeutics, Inc. | COM | 40,325 | $128.0K | <0.1% | History |
| LCIDLucid Group, Inc. | COM | 21,439 | $120.0K | <0.1% | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 21,535 | $114.0K | <0.1% | History |
| MCRBSeres Therapeutics, Inc. | COM | 48,095 | $114.0K | <0.1% | History |
| KURAKura Oncology, Inc. | COM | 11,929 | $109.0K | <0.1% | History |
| AGENAgenus Inc | COM NEW | 86,343 | $98.0K | <0.1% | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 13,939 | $93.0K | <0.1% | History |
| MDXGMimedx Group, Inc. | COM | 11,535 | $84.0K | <0.1% | History |
| PNTPOINT Biopharma Global Inc. | COM | 11,463 | $76.0K | <0.1% | History |
| EQRXEQRx, Inc. | COM | 26,843 | $60.0K | <0.1% | History |
| LYELLyell Immunopharma, Inc. | COM | 21,829 | $32.0K | <0.1% | History |